K-group, Beta, Inc., A Wholly Owned Subsidiary Of Zentalis Pharmaceuticals, Inc

This study tests a new drug, azenosertib (ZN-c3), in people with a type of ovarian cancer that no longer responds to platinum chemotherapy. About 310 adults with high-grade serous ovarian, fallopian tube, or primary peritoneal cancer will receive the drug to see if it shrinks tum…